Researchers from Boston Children’s Hospital and collaborators have developed a method accelerating vascular organoid formation from human iPSCs by dual transcription factor activation. This technique co-differentiates endothelial and mural cells to produce self-assembling and functional vessels capable of host integration. Published in Cell Stem Cell, the approach offers a powerful platform for vascular biology, tissue engineering, and regenerative medicine applications.